Harvard Health Blog

It’s NOT a “pink Viagra”

Posted August 21, 2015, 8:16 am Hope Ricciotti, M.D., Editor in Chief, Harvard Women's Health Watch Many of my patients, colleagues, friends, and even neighbors have asked me about the new drug flibanserin (brand name Addyi). Just this past Tuesday, the FDA approved this drug for treatment of low sexual desire in women. Flibanserin has generated more questions, comments, and media inquiries for me than Iíve ever experienced in my 20-year career as…

To continue reading this article you must be registered.

Get Licensed Content to Harvard Health

If you are interested in licensing content from Harvard Health Publications, please contact us using our online form. Our licensing and business development professionals will help you leverage consumer health content from Harvard Medical School as a clear differentiator in helping achieve your business goals.

Contact Us

Customer Log In